UK] and serum C-telopeptide (CTx) [Roche Elecsys, as measured on the Elecsys 2010 automated analyser, Mannheim, Germany] to assess rate of bone resorption, and serum bone-specific alkaline ...

BAP, bone-specific alkaline phosphatase; BSP, bone sialoprotein; CTX, C-terminal telopeptide of type I collagen; PINP, N-terminal propeptide of type 1 collagen; TRAcP, tartrate-resistant acid ...

C is a programming language designed by Dennis Ritchie at Bell Labs. C is very widely used, straightforward, and can be compiled to a number of platforms and operating systems. C is an imperative ...

BMD, bone mineral density; CTX, C-terminal cross-linked telopeptide of type I collagen; HbA1c, glycosylated hemoglobin; LRP, low-density lipoprotein receptor-related protein; P1NP, N-terminal ...

CTX-320 is under clinical development by CRISPR Therapeutics and currently in Phase I for Atherosclerosis. According to GlobalData, Phase I drugs for Atherosclerosis have a 64% phase transition ...

A gene-editing drug developed by CRISPR Therapeutics and Vertex Pharma has achieved “remarkable” improvements in patients with beta thalassaemia and sickle cell disease in an early-stage trial ...